Study on the effect of 150-mg Mydocalm coated tablets in peripheral vascular diseases and in myotonias of various origin
Abrányi, I.
Therapia Hungarica 36(2): 56-61
1988
ISSN/ISBN: 0133-3909 PMID: 3201387 Document Number: 323321
Document emailed within 1 workday
Related Documents
Iliaszenko, J.; Sokołowska, M.; Paruszewski, R. 2001: Gravimetric and spectrophotometric determination of some phenothiazine and imidazole derivatives in coated tablets and tablets Acta Poloniae Pharmaceutica 58(6): 411-413Van Bellen, B. 1977: The Doppler effect in the diagnosis of non-invasive peripheral vascular diseases Amb: Revista da Associacao Medica Brasileira 23(7): 254-256
Rowe, R.C. 1982: The effect of pigment type and concentration on the incidence of edge splitting on film-coated tablets Pharmaceutica Acta Helvetiae 57(8): 221-225
Korsatko-Wabnegg, B. 1990: Development of press-coated tablets with controlled-release effect with a base of poly-d(-)-3-hydroxybutyric acid Die Pharmazie 45(11): 842-844
Davydova, L.I. 1978: Study of central and peripheral hemodynamics in obliterative vascular diseases of the extremities Klinicheskaia Khirurgiia 7: 50-52
Silvestrini, P.; Raso, A.M. 1972: Peridural anesthesia in vascular surgery. I. use of it in surgical treatment of peripheral vascular diseases Chirurgia 21(7): 651-657
Czarnecki, W.; Belniak, P. 2009: Tablets coated with the novel starch hydrolysate emulsion Acta Poloniae Pharmaceutica 66(4): 429-431
Spang, R. 1982: Breakability of tablets and film-coated dragees Pharmaceutica Acta Helvetiae 57(4): 99-111
Di Cesare, E.; Quartarone, M.; Coglitore, G.; Perdichizzi, G.; Saitta, A.; Longo, G.; Squadrito, G. 1978: Antithrombin IIi and peripheral vascular diseases Bollettino Della Societa Italiana di Cardiologia 23(2): 347-353
Havlik, J.; Holý, M. 1976: Erythromycin stearate Spofa--coated tablets for pediatric practice Ceskoslovenska Pediatrie 31(7): 402-404
Sztankay, C. 1970: Bencyclane in the therapy of peripheral vascular diseases Arzneimittel-Forschung 20(Suppl 10a): 1426
Mostarda, G.F. 1970: Antalgic treatment of peripheral vascular diseases Minerva Anestesiologica 36(9): 575-612
Garcia, Cássia.V.; Paim, Césio.S.; Steppe, M. 2004: New liquid chromatographic method for determination of rabeprazole sodium in coated tablets Journal - Association of Official Analytical Chemists 87(4): 842-846
Kowal-Gierczak, B.; Kurzawska-Mielecka, M.; Wysokiński, W. 1986: Clinical experiences with the treatment of peripheral vascular diseases Materia Medica Polona. Polish Journal of Medicine and Pharmacy 18(1): 24-28
Masłowski, L.; Sawicki, G. 1987: Circulating immune complexes in peripheral vascular diseases Kardiologia Polska 30(4): 238-243
Raghubanshi, R.S.; Jayaswal, S.B.; Singh, J. 1991: Controlled-release tablets of ethyl cellulose coated salbutamol sulphate microcapsules Die Pharmazie 46(2): 144-145
Chalabala, M.; Starha, L. 1970: Peroral, compounded long-acting drugs. 3. Tablets coated with Eudragite retard Ceskoslovenska Farmacie 19(5): 184-186
Najafpour, H.D.; Suzina, A.H.; Nizam, A.; Samsudin, A.R. 2004: A comparative study of osseointegration phenomenon in coated and non-coated NiTi implants in a rabbit model Medical Journal of Malaysia 59 Suppl B: 121-122
Strozzi, C.; Malin, L.; Cocco, G.; Longhini, C. 1977: Thrombolytic treatment of peripheral thromboembolic vascular diseases using streptokinase La Clinica Terapeutica 83(2): 135-150
Tanamai, J.; Veeramanomai, S.; Indrakosas, N. 2004: The efficacy of cholesterol-lowering action and side effects of garlic enteric coated tablets in man Journal of the Medical Association of Thailand 87(10): 1156-1161